Mayo Clinic Laboratory and Pathology Research Roundup: April 30
The Research Roundup provides an overview of the past week’s research from Mayo Medical Laboratories consultants, including featured abstracts and complete list of published studies and reviews.
Featured Abstract
Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia
Women with atypical hyperplasia (AH) on breast biopsy have an aggregate increased risk of breast cancer (BC), but existing risk prediction models do not provide accurate individualized estimates of risk in this subset of high-risk women. Here, Mayo Clinic researchers used the Mayo benign breast disease cohort to develop and validate a model of BC risk prediction that is specifically for women with AH, which we have designated as AH-BC. Retrospective cohorts of women age 18 to 85 years with pathologically confirmed benign AH from Rochester, MN, and Nashville, TN, were used for model development and external validation, respectively. The model-building set consisted of 699 women with AH, 142 of whom developed BC, and the external validation set consisted of 461 women with 114 later BC events. The final AH-BC model included three covariates: age at biopsy, age at biopsy squared, and number of foci of AH. Researchers created a new model with which to refine BC risk prediction for women with AH. The AH-BC model demonstrates good discrimination and calibration, and it validates in an external data set. The study was published in the Journal of Clinical Oncology.
Published to PubMed This Week
-
-
-
-
- CX3CR1 Identifies PD-1 Therapy-Responsive CD8+ T Cells That Withstand Chemotherapy During Cancer Chemoimmunotherapy
JCI Insight - Colorectal-Vaginal Fistulas: Imaging and Novel Interventional Treatment Modalities
Journal of Clinical Medicine - Association of Polygenic Risk Score with the Risk of Chronic Lymphocytic Leukemia and Monoclonal B-cell Lymphocytosis
Blood - Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients With Melanoma Treated With Pembrolizumab
Clinical Cancer Research - Biomarkers Associated with Progression of Diabetic Kidney Disease: Do They Hold the Same Meaning for Blacks and Women?
Journal of the American Society of Nephrology - Plasma Cell Proliferative Index Predicts Outcome in Immunoglobulin Light Chain Amyloidosis Treated with Stem Cell Transplantation
Haematologica - The Impact of Sex on Disease Phenotype and Prognostic Thresholds of Anemia in Myelodysplastic Syndromes
American Journal of Hematology - Ethnic Disparity in Primary Cutaneous CD30 T-Cell Lymphoproliferative Disorders: An Analysis of 1496 Cases From the U.S. National Cancer Database
British Journal of Haematology - Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience
Oncologist - Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome Without Significantly Impacting Measured Pulmonary Functions
Biology of Blood and Marrow Transplantation - RNAi Screening Identifies a Mechanosensitive ROCK-JAK2-STAT3 Network Central to Myofibroblast Activation
Journal of Cell Science - The Brief Case: A "Fresh" Pair of Contact Lenses
Journal of Clinical Microbiology - Closing The Brief Case: A "Fresh" Pair of Contact Lenses
Journal of Clinical Microbiology - Utility of DNA, RNA, Protein, and Functional Approaches to Solve Cryptic Immunodeficiencies
Journal of Clinical Immunology - Use of Genetic Testing for Primary Immunodeficiency Patients
Journal of Clinical Immunology - Bim is an Independent Prognostic Marker in Intrahepatic Cholangiocarcinoma
Human Pathology - Prehospital Blood Product Administration Opportunities in Ground Transport ALS EMS - A Descriptive Study
Prehospital and Disaster Medicine - Sitting Versus Standing Makes a Difference in Musculoskeletal Discomfort and Postural Load for Surgeons Performing Vaginal Surgery
International Urogynecology Journal - A Cavernous Sinus Lesion Clinically Responsive to Steroids
Journal of Clinical Neuroscience
- CX3CR1 Identifies PD-1 Therapy-Responsive CD8+ T Cells That Withstand Chemotherapy During Cancer Chemoimmunotherapy
-
-
-